Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Uromedica, Inc. logo — Manufacturer of ProACT and ACT - minimally invasive, adjusta...

Uromedica, Inc.

Manufacturer of ProACT and ACT - minimally invasive, adjustable balloon devices designed to treat SUI.

Founded 1997 United States Plymouth, United States 30 employees Undisclosed Total: $3.35M Biotechnology

General Information

Company Name Uromedica, Inc.
Founded Year 1997
Location United States Plymouth, United States +1
Employees 30
Industries Biotechnology
Funding Stage Undisclosed
Social

Get notified when Uromedica, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Uromedica, Inc.

Uromedica, Inc. is a Minnesota-based biotechnology startup established in 1997. Specializing in the development of minimally invasive, adjustable balloon devices for the treatment of stress urinary incontinence (SUI), the company manufactures ProACT and ACT. These innovative products have been successfully implanted in over 16,000 patients worldwide, delivering outstanding results. The company's flagship product, ProACT, received FDA approval for sale in the USA in November 2015, marking a significant milestone for Uromedica. Meanwhile, ACT is undergoing clinical trials for its female application and is not yet available for sale in the USA. Uromedica's implantable balloon therapies help address male and female stress urinary incontinence by providing long-term solutions that are incredibly safe and effective. The implantation procedure, which only takes approximately 30 minutes, offers patients a minimally invasive treatment option. Notably, the balloons can be adjusted post-operatively through a subcutaneous port and can be easily removed during a short office visit if necessary. In January 17, 2019, Uromedica received a $600.00K investment in its latest funding round, reflecting continued investor confidence in the company's pioneering medical technologies. Uromedica's dedication to addressing a prevalent medical issue in a minimally invasive manner positions the company as an innovative player in the biotechnology industry, with considerable potential for growth and further impactful contributions to the field of medical devices.

Taxonomy: medical device, minimally invasive, adjustable balloon devices, stress urinary incontinence, implantable therapies, clinical trial, FDA-approved, female application, urology, Minnesota-based, subcutaneous port, implantation procedure

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Funding Round •••••• - 17 Jan 2019
Debt Financing •••••• - 28 Dec 2012
Series A •••••• - 31 Oct 2007

Uromedica, Inc. Alternatives & Competitors

Uromedica, Inc. vs
MetaCure
MetaCure Bermuda

MetaCure, member of the Hobart Group companies, aims to provide a better way to manage type 2 diabet...

Series B
6 employees
Biotechnology
Compare Uromedica, Inc. vs MetaCure
Uromedica, Inc. vs
Peso
Peso

Peso has arrived to help you discover the deals you were looking for and even those you never knew e...

Seed
53 employees
Analytics, E-Commerce
Compare Uromedica, Inc. vs Peso
Uromedica, Inc. vs
MedVasc
MedVasc Sweden

The new painless treatment for Varicose Veins

Seed
4 employees
Medical Devices
Compare Uromedica, Inc. vs MedVasc

FAQ About Uromedica, Inc.

Manufacturer of ProACT and ACT - minimally invasive, adjustable balloon devices designed to treat SUI.
Uromedica, Inc. was founded in 1997.
Uromedica, Inc. is headquartered in Plymouth, United States.
Uromedica, Inc. operates in the following industries: Biotechnology.
Uromedica, Inc. has approximately 30 employees.
Uromedica, Inc. has completed 3 funding rounds, raising a total of $3.35M. The latest funding stage is Undisclosed.
Top alternatives and competitors to Uromedica, Inc. include MetaCure, Peso, MedVasc, BUY WOMEN BUILT, Replenish, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Uromedica, Inc. and MetaCure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Uromedica, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes